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Functional interactions in signaling occur between dopamine D2 (D2R) and cannabinoid 
CB1 (CB1R) receptors, between CB1R and adenosine A2A (A2AR) receptors, and between 
D2R and A2AR. Furthermore, direct molecular interactions have been reported for the 
pairs CB1R-D2R, A2AR-D2R, and CB1R-A2AR. Here a combination of bimolecular 
fluorescence complementation and bioluminescence energy transfer techniques was 
used to identify the occurrence of D2R-CB1R-A2AR hetero-oligomers in living cells.  
KEYWORDS: G-protein-coupled receptors, adenosine A2A receptor, cannabinoid CB1 receptor, 
dopamine D2 receptor, heterotrimers, oligomers of three different protomers, bimolecular 
fluorescence complementation, bioluminescence energy transfer, BRET 
 
INTRODUCTION 
The mechanism of action responsible for the motor-depressant effects of cannabinoids, which operate 
through centrally expressed cannabinoid CB1 receptors (CB1R), is still a matter of debate. The cellular 
and subcellular localization of CB1R and D2 receptors (D2R) in the basal ganglia have been described in 
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detail[1,2,3,4,5]. The evidence suggests a colocalization of striatal CB1R and D2R predominantly in the 
soma and dendrites of the GABA enkephalinergic neurons and also in corticostriatal glutamate terminals 
where A2A receptors (A2AR) are also present[5,6,7,8,9,10]. 
Functional interactions between CB1R and A2AR or D2R receptors that are relevant for striatal 
function have been reported. Thus, CB1R and A2AR form heteromers in cotransfected HEK-293T cells 
and in rat striatum[11]. In a human neuroblastoma cell line, CB1R signaling was found to be completely 
dependent on A2AR activation. Accordingly, blockade of A2AR counteracted the motor-depressant effects 
produced by the intrastriatal administration of a CB1R agonist[11]. The existence of CB1R-D2R 
heteromers has been demonstrated in transfected cell lines by coimmunoprecipitation[12] and by 
fluorescence resonance energy transfer (FRET) experiments[13]. Antagonistic CB1R-D2R interactions 
have been discovered at the behavioral level[13,14,15,16]. In rats, the CB1R receptor agonist CP 55,940 
at a dose that did not change basal locomotion was able to block quinpirole-induced increases in 
locomotor activity. In addition, not only the CB1R antagonist rimonabant, but also the specific A2AR 
antagonist MSX-3, blocked the inhibitory effect of CB1R agonist on D2-like receptor agonist-induced 
hyperlocomotion[13]. Taken together, these results give evidence for the existence of antagonistic CB1-D2 
receptor-receptor interactions within CB1R-D2R heteromers in which A2AR may also participate. 
A2AR-D2R was one of the first reported heteromers[17]. A close physical interaction between both 
receptors has been shown using coimmunoprecipitation and colocalization assays[17], and FRET and 
bioluminescence resonance energy transfer (BRET) techniques[18,19,20]. At the biochemical level, two 
kinds of antagonistic A2AR-D2R interactions have been discovered that can explain the A2AR-D2R 
interaction observed at both the functional and behavioral levels[9,21,22,23]. First, by means of an 
intramembrane interaction, i.e., by intramolecular cross-talk within the heterodimer, stimulation of A2AR 
decreases the affinity of D2R for their agonists[24]. Second, the stimulation of D2R, a Gi/o protein–
coupled receptor, inhibits the cAMP accumulation induced by the stimulation of the Gs/olf protein–
coupled A2AR[17]. Therefore, it has been suggested that the A2AR-D2R interaction cross-talk in the central 
nervous system may provide new therapeutic approaches for Parkinson’s disease, schizophrenia, and drug 
addiction[23,25]. 
Since trimers formed by cannabinoid, adenosine, and dopamine receptors were suspected, strategies 
to detect them were developed in our laboratory. In one of them, trimers were detected by sequential 
application of BRET and FRET[26]. In this paper, the formation of hetero-oligomer complexes formed by 
cannabinoid CB1, dopamine D2, and adenosine A2A G-protein-coupled receptors (GPCRs) is confirmed by 
another technique[27], which consists of combining bimolecular fluorescence complementation and 
bioluminescence energy transfer.  
MATERIALS AND METHODS 
Cell Culture 
HEK-293T cells were grown in Dulbecco’s modified Eagle’s medium (DMEM) (Gibco) supplemented 
with 2 mM L-glutamine, 100 U/ml penicillin/streptomycin, and 5% (v/v) heat inactivated fetal bovine 
serum (FBS) (all supplements were from Invitrogen, Paisley, Scotland, U.K.). Cells were maintained at 
37ºC in an atmosphere of 5% CO2, and were passaged when they were 80–90% confluent, i.e., 
approximately twice a week.  
Fusion Proteins and Expression Vectors 
Full-length YFP was subcloned in the XhoI site of pcDNA3.1 vector (Invitrogen). The N-terminal 
truncated version of YFP, named nYFP (amino acids 1 to 155), was made by PCR amplification and 
cloning into the XhoI site of pcDNA3.1 using the following primers: FnYFP (5’-
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CCGCTCGAGACCATGGTGAGCAAGGGCGAGGAGC-3’) and RnYFP (5’-
CCGTCTAGATCAGGCCATGATATAGACGTTG-3’). Also, a C-terminal truncated version of YFP, 
named cYFP (amino acids 155 to 231), was made using the same strategy and the following primers: 
FcYFP (5’-CCGCTCGAGACCATGGACAAGCAGAAGAACGGC-3’) and RcYFP (5’-
CCGTCTAGATTACTTGTACAGCTCGTCCAT-3’). Gαs cloned in SFV1 vector (generously given by 
H. Vogel, Ecole Politecnique Federal de Laussane, Switzerland) or Gγ and Gβ cloned in pEYFP-C1 vector 
(generously provided by S. Cotecchia, Department of Pharmacology and Toxicology, University of 
Lausanne, Switzerland) were amplified to miss their stop codons using sense and antisense primers 
harboring unique NheI and BamHI sites to clone Gα and Gβ in pcDNA3.1-nYFP and pcDNA3.1-cYFP, 
respectively, and HindIII and BamHI sites to clone Gγ in Rluc vector (pRluc-N1 PerkinElmer, Wellesley, 
MA). The amplified fragments were subcloned to be in-frame with the multiple cloning site of the vectors 
to give the plasmids Gα-nYFP, Gβ-cYFP, and Gγ-Rluc, respectively. All plasmids express luminescent or 
part of fluorescent proteins on the C-terminal ends of proteins. The human cDNAs for A2AR, CB1R, D2R, 
or D4.4R cloned in pcDNA3.1 were amplified without their stop codons using sense and antisense primers 
harboring unique NheI and BamHI sites to clone A2AR, CB1R, and D2R in pcDNA3.1-cYFP, pcDNA3.1-
nYFP, and pRluc-N1, respectively, and XhoI and BamHI sites to clone D4.4R in pRluc-N1 vector. The 
amplified fragments were subcloned to be in-frame with the multiple cloning site of the vectors to give 
the plasmids A2A-cYFP, CB1-nYFP, D2-Rluc, or D4-Rluc. 
Transient Transfection and Protein Determination 
HEK-293T cells growing in six-well dishes were transiently transfected with the corresponding fusion 
protein cDNAs by PEI (PolyEthylenImine, Sigma, Steinheim, Germany) method. Cells were incubated 
with the corresponding cDNA, 5.47 mM (in nitrogen residues) PEI, and 150 mM NaCl in a serum-free 
medium. After 4 h, cells were placed in a fresh complete culture medium. Forty-eight hours after 
transfection, cells were rapidly washed twice in HBSS containing 10 mM glucose, detached, and 
resuspended in the same buffer. To control for cell number, sample protein concentration was determined 
using a Bradford assay kit (Bio-Rad, Munich, Germany) using bovine serum albumin as reference. Cell 
suspension (20 µg of protein) was distributed into 96-well black plates with a transparent bottom for 
fluorescence determinations or white plates with white bottom for BRET experiments. 
Fluorescence Measurements 
To quantify fluorescence, cells (20 µg protein) were distributed in 96-well microplates (black plates with 
a transparent bottom) and fluorescence was read in a Mithras LB 940 (Berthold Technologies, DLReady, 
Germany) using a 10-nm bandwidth excitation and emission filters at 485 and 530 nm, respectively. 
Protein fluorescence expression was determined as fluorescence of the sample minus the fluorescence of 
cells that were not transfected. 
BRET Assays with Bimolecular Fluorescence Complemented Proteins 
HEK-293T cells were transiently cotransfected with a constant amount of cDNA encoding for the protein 
fused to Rluc and with increasingly equal amounts of cDNA corresponding to proteins fused to one of the 
two complementary parts of the YFP protein (nYFP and cYFP). Fluorescence was measured as indicated 
above. The equivalent to 20 µg of cell suspension was distributed in 96-well microplates (Corning 3600, 
white plates with white bottom) and 5 µM coelenterazine H (Molecular Probes, Eugene, OR) was added. 
After 1-min delay, collection of readings started using a Mithras LB 940, which allows the integration of 
the signals detected in the short-wavelength filter at 485 nm (440–500 nm) and the long-wavelength filter 
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at 530 nm (510–590 nm). To quantify for protein-Rluc expression, luminescence readings were performed 
after 10 min of adding 5 µM coelenterazine H. The net BRET is defined as [(long-wavelength 
emission)/(short-wavelength emission)]-Cf, where Cf corresponds to [(long-wavelength emission)/(short-
wavelength emission)] for the Rluc construct expressed alone in the same experiment.  
Immunostaining 
For immunocytochemistry, transiently transfected HEK-293T cells were fixed in 4% paraformaldehyde 
for 15 min and washed with PBS containing 20 mM glycine (buffer A) to quench the aldehyde groups. 
Then, after permeabilization with buffer A containing 0.2% Triton X-100 for 5 min, cells were treated 
with PBS containing 1% bovine serum albumin. After 1 h at room temperature, cells expressing D2R-Rluc 
were labeled with the primary mouse monoclonal anti-Rluc antibody (1/100, Chemicon) for 1 h, washed, 
and stained with the secondary antibody Cy3 Donkey antimouse (1/100, Jackson Immunoresearch 
Laboratories, Baltimore, PA). Heterodimers of receptors fused to complementary fragments of YFP were 
detected by their fluorescence properties. Samples were rinsed and observed in a Leica SP2 confocal 
microscope (Leica Microsystems, Mannheim, Germany).  
RESULTS AND DISCUSSION 
In the early 1980s, and based on indirect functional evidence, it was proposed that GPCRs could interact 
at the level of the neuronal plasma membrane. In the early 1990s, electrophoretic mobility and 
coimmunoprecipitation assays gave the first indication of GPCR homomerization. More recently, the 
development of the biophysical techniques BRET and FRET allowed the demonstration of GPCR 
homodimerization and heteromerization of two GPCRs in living cells[23,28,29,30,31,32,33,34,35,36]. 
Nevertheless, the lack of assays monitoring interactions between more than two proteins simultaneously 
makes it very difficult to draw a map of molecular networks involving protein-protein interactions. By the 
approach previously reported by Héroux et al.[27], we here show that the combination of bimolecular 
fluorescence complementation and bioluminescence energy transfer is useful to detect heteromerization 
of three different GPCRs.  
For bimolecular fluorescence complementation assay, the reconstitution of a reporter fluorescence 
protein (YFP) from its two fragments attached to the potential interacting protein partners under 
study[37,38] is taken as evidence for the molecular interaction between the partners[39]. The usefulness of 
the bimolecular fluorescence complementation technique to detect protein heterodimers was proved using 
cells transfected with the following subunits of heterotrimeric G proteins: GαnYFP and GβcYFP. Positive 
complementation was detected by the increase of fluorescence at 530 nm upon increasing the amount of 
transfected proteins (Fig. 1). As negative control, no signal was detected when either GαnYFP and cYFP, or 
GβcYFP and nYFP, were cotransfected (Fig. 1). These results prove the ability of the bimolecular 
complementation technique to detect heterodimers. The bimolecular fluorescence complementation 
technique was used to detect CB1R-A2AR heterodimers in HEK-293 cells. Fusion of nYFP and cYFP 
fragments to CB1R or to A2AR did not prevent the receptor functionality determined as ERK1/2 
phosphorylation (results not shown). Cells transfected with CB1RnYFP and A2ARcYFP (see Methods) 
showed fluorescence at the membrane level (Fig. 2A). No fluorescence was detected when cells were 
cotransfected with A2ARcYFP and nYFP (Fig. 2A) or with CB1RnYFP and cYFP (results not shown), 
showing the specificity of the signal. In agreement, positive complementation was detected by the increase 
of fluorescence at 530 nm upon increasing the amount of transfected receptors (Fig. 2B). As a negative 
control, no signal was detected when either A2ARcYFP and nYFP, or CB1RnYFP and cYFP, were 
cotransfected (Fig. 2B). Taken together, these results validate the usefulness of the bimolecular fluorescence 
complementation technique to monitor the formation of CB1R-A2AR heteromers.  
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FIGURE 1. Molecular interaction between Gα and Gβ subunits of heterotrimeric 
G proteins detected by bimolecular fluorescence complementation. HEK-293 
cells were cotransfected with equal amounts of cDNAs corresponding to the 
fusion proteins GαnYFP and GβcYFP (black), GαnYFP and cYFP (white), or 
GβcYFP and nYFP (grey). Forty-eight hours post-transfection, fluorescence was 
determined at 530 nm. Values are mean ± SEM of four independent 
experiments. One-way ANOVA followed by Newman-Keuls test showed 
significant differences respective to both negative controls. ***p < 0.001. 
       
A 
FIGURE 2. CB1R-A2AR heterodimers in HEK-293 cells. HEK-293 cells were cotransfected with (A) 2 µg of 
cDNA corresponding to the fusion proteins CB1RnYFP and A2ARcYFP (left panel), or A2ARcYFP and nYFP 
(right panel) or (B) equal amounts of cDNAs corresponding to CB1RnYFP and A2ARcYFP (black), A2ARcYFP 
and nYFP (grey), or CB1RnYFP and cYFP (white). In (A), confocal microscopy images obtained 48 h post-
transfection are shown. In (B), fluorescence at 530 nm was determined 48 h post-transfection. Values are mean 
± SEM of four independent experiments. One-way ANOVA followed by Newman-Keuls test showed 
significant differences respective to both negative controls. ***p < 0.001. 
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FIGURE 2B 
The positive results on the formation of CB1R-A2AR heteromers, obtained by the bimolecular 
fluorescence complementation technique, opened the possibility of combining this technology with BRET 
to investigate the existence of D2R-CB1R-A2AR hetero-oligomers. The usefulness of the combination of 
the bimolecular fluorescence complementation technique and BRET to detect oligomers formed by three 
different proteins was first tested by transfecting the following fusion proteins of the three subunits of 
heterotrimeric G proteins: Gγ-Rluc, GαnYFP, and GβcYFP. Positive BRET was detected between Gγ-Rluc 
and complemented GαnYFP-GβcYFP. A hyperbolic BRET saturation curve was obtained upon increasing 
the GαnYFP-GβcYFP expression (Fig. 3A). This result proves the ability of the combination of the two 
techniques to detect trimolecular protein complexes as those detected for functional calcitonin gene-
related peptide receptors, which are formed by the asymmetric assembly of a calcitonin receptor-like 
receptor homo-oligomer and a monomer of receptor activity-modifying protein-1[27]. 
In order to detect possible formation of hetero-oligomers composed of CB1, D2, and A2A receptors, 
HEK-293 cells were transfected with D2RRluc, A2ARcYFP, and CB1RnYFP. Fusion of Rluc to D2R did 
not prevent the receptor functionality determined as ERK1/2 phosphorylation (results not shown). Fusion 
proteins did not affect the normal subcellular distribution of receptors (Fig. 3B). In fact, these receptors 
are predominantly colocalized in the plasma membrane of cotransfected cells. In conditions to give a 
BRET50 fusion protein expression levels, measured as described previously[26] by radioligand binding in 
different experimental sessions, were between 0.5 and 0.7 pmols/mg protein for A2ARcYFP, between 0.9 
and 1.1 pmols/mg protein for D2RRluc, and between 0.6 and 0.8 pmols/mg protein for CB1RnYFP. 
Triggering with coelenterazin H, these transfected cells gave a significant BRET signal. The BRET signal 
was specific as assessed by the saturation hyperbola obtained upon increasing the complemented 
A2ARcYFP-CB1RnYFP expression and by the lack of the signal using D4Rluc instead of D2Rluc as a 
negative control (Fig. 3C). These data indicate that D2R, CB1R, and A2AR form, at least, trimolecular 
oligomers in cotransfected living cells. This technique is validated by the identification of D2-CB1- and 
A2A receptor heteromers by sequential resonance energy transfer (SRET)[26]. Apart from transmembrane 
regions, basic and acidic residues are involved in the epitope-epitope electrostatic interactions existing in 
D2-A2A receptor heteromers. In fact, mass spectometry and pull-down assays have been instrumental to 
show that the Arg-rich D2R epitope may bind to two different epitopes in the C-terminal part of the A2AR, 
one containing two adjacent Asp residues and another containing a phosphorylated Ser residue[18,20]. 
Then, it might be possible that one of the epitopes is involved in the interaction with D2 and another in the 
interaction with CB1. Further experimental work is necessary, however, to elucidate the amino acids 
constituting the interfaces in the D2-CB1-A2A hetero-oligomer. 
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A 
 
B 
 
C 
FIGURE 3. D2R-CB1R-A2AR heteromers detected by a combination of bimolecular fluorescence complementation and 
BRET. In (A), as a positive control, BRET saturation curve was performed using HEK-293 cells cotransfected with 0.75 
µg of cDNA corresponding to the fusion protein Gγ-Rluc (100,000 bioluminescence units) and increasing equal amounts 
of cDNAs corresponding to GαnYFP and GβcYFP (1000–6000 fluorescence units). In (B), confocal microscopy image of 
a cell after 48 h of transfection with 1 µg of cDNA corresponding to D2RRluc, 2 µg of cDNA corresponding to 
CB1RnYFP, and 2 µg of cDNA corresponding to A2ARcYFP. Proteins were identified by fluorescence (green image) or 
by immunocytochemistry (red image) using a monoclonal anti-Rluc primary antibody and a cyanine-3-conjugated 
secondary antibody. Colocalization is shown in yellow in the right image. In (C), BRET saturation curve (red) was 
obtained using HEK-293 cells cotransfected with 1.5 µg of cDNA corresponding to D2RRluc (100,000 bioluminescence 
units) and increasing equal amounts of cDNAs corresponding to CB1RnYFP and A2ARcYFP (1000–10,000 fluorescence 
units). As negative controls, cells were transfected with 1.5 µg of either the cDNA for D4Rluc (black line) or for 
GABAB2Rluc (green line) (100,000 bioluminescence units in each case). 
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There has been reported a coexpression of D2R and A2AR in GABAergic striatal neurons (see [9]) and 
of CB1R and A2AR in rat striatal fibrillar structures[11,13]. The demonstration of D2R-CB1R-A2AR 
heteromers in transfected cells, together with such striatal codistribution of the three receptors in the 
plasma membrane of striatal neurons, strongly suggests that these three receptors are forming part of a 
molecular network. The function of these neurons is particularly compromised in Parkinson’s disease and 
in the early stages of Huntington’s disease[21]. Furthermore, neuroadaptations of glutamatergic synapses 
of GABAergic enkephalinergic neurons localized in the nucleus accumbens (the ventral part of the 
striatum) seem to be involved in compulsive drug seeking and relapse[40]. Based on the existence of 
antagonistic interactions between A2AR and D2R in the A2AR-D2R heteromer[21,25], A2AR antagonists are 
giving successful results in clinical trials in patients with Parkinson’s disease[41]. Furthermore, A2AR 
antagonists are being considered as possible therapeutic agents in end-stage drug addiction[42]. Their 
clinical efficacy might be related to the recently demonstrated dependence of A2AR activation for CB1R 
receptor signaling within the striatal A2AR-CB1R heteromers[11]. Thus, A2AR antagonists behave as CB1R 
antagonists, known to counteract cue-induced reinstatement of different addictive drugs in the 
experimental animal, a model for human relapse[43]. Although the intramembrane and intracellular cross-
talk established by complexes formed by receptor heterodimers is already important to understand better 
the function of striatal enkephalinergic neurons, the occurrence of oligomers formed by three different 
receptors indicate a more diverse interplay between receptors for neurotransmitters. Taken together, the 
results already reported in the literature suggest that the A2AR-CB1R-D2R receptor heteromer may act as a 
processor mediating the neuronal computation needed to modulate striatal dopamine neurotransmission. 
The demonstration of D2R-CB1R-A2AR heteromers in transfected cells, together with their striatal 
codistribution, opens new perspectives to understand the interplay between different neurotransmitter-
neuromodulator systems. Pharmacological and functional diversification expand in a macromolecular 
complex containing three receptors by the same simple events as described for dimers, i.e., by (1) a 
change in the pharmacological profile of a receptor when another receptor in the complex is activated and 
(2) a change in the associated signaling response-pathways depending on the receptors present in the 
complex, their degree of activation, and the nature of the G proteins expressed in the horizontal molecular 
network involved[44]. 
The combination of bimolecular fluorescence complementation and bioluminescence energy transfer 
techniques constitutes a powerful approach to detect the protein-protein interactions localized in the plane 
of the membrane, and thus allows identification of the horizontal molecular networks like the receptor 
networks in local circuits. This new knowledge will hopefully provide novel therapeutic approaches for 
neurodegenerative diseases, mental disorders, and drug addiction.  
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